Arcadia Biosciences (RKDA) revenue and earnings history
Arcadia Biosciences reported revenue of $4.86M for fiscal 2025 (year ended Dec 31, 2025), −3.7% on the year before, and net income of −$2.34M.
Over 11 years, from fiscal 2014 to fiscal 2025, revenue grew at a compound rate of −3.2% a year.
Revenue and net income, 12 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $4.86M−3.7% | −$2.5M | −$2.34M | — | $0 | — | $234K | — | — | $259K | — | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Arcadia Biosciences (RKDA) on OQRO.
Common questions
What was Arcadia Biosciences's revenue in fiscal 2025?
$4.86M for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 26, 2026. That is −3.7% on fiscal 2024 ($5.04M).
How fast has Arcadia Biosciences's revenue grown?
From $6.98M in fiscal 2014 to $4.86M in fiscal 2025: a compound annual growth rate of −3.2% over 11 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Arcadia Biosciences been profitable?
It reported a net loss in 12 of the years shown (2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025). The highest net income was −$2.34M in fiscal 2025.
Where these figures come from
The SEC’s companyfacts data: every figure Arcadia Biosciences tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
